Using β2-stimulants in asthma

Drug and Therapeutics Bulletin

Volumn 35, Issue 1, 1997, Pages 1-4

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BAMBUTEROL; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; FORMOTEROL; NEDOCROMIL; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE;

ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CLINICAL TRIAL; EMERGENCY MEDICINE; HEADACHE; HEART PALPITATION; HUMAN; HYPOKALEMIA; INHALATIONAL DRUG ADMINISTRATION; INHALER; MUSCLE CRAMP; NEBULIZER; ORAL DRUG ADMINISTRATION; PATIENT CARE; SHORT SURVEY; SIDE EFFECT; SYMPTOM; TREMOR; VERTIGO;

EID: 0031033969     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1997.3511     Document Type: Short Survey

References (32)

1. The British Thoracic Society, the British Paediatnc Association, the Research Unit of the Royal College of Physicians of London et at. Guidelines on the management of asthma. Thorax 1993; 48 (suppl): S1-24.
2. Greening AP, Ind PW, Northfield M, Shaw G on behalf of Allen & Hanburys Limited UK Study Group. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344. 219-24.
3. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481-8.
4. Salmeron S, Brochard L, Mal H et al. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicentre, double-blind, randomized study. Am J Respir Crit Care Med 1994; 149: 1466-70.
5. McCarthy TP, Lenney W. Management of asthma in pre-school children. Br J Gen Pract 1992; 42: 429-34.
6. Yuksel B, Greenough A. Comparison of the effects on lung function of two methods of bronchodilator administration. Respir Med 1994; 88: 229-33.
7. Bentur L, Canny GJ, Shields MD et al. Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma. Pediatrics 1992; 89 133-7.
8. Tattersfield AE, Britton JR. ß-adrenoceptor agonists In: Barnes PJ, Rodger IW, Thomson NC (Eds). Asthma, Basic mechanisms and chnical management. Second edition. London: Academic Press Limited, 1992.
9. Sears MR, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma Lancet 1990; 336 1391-6.
10. Crane J, Pearce N, Flatt A et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case control study. Lancet 1989, i: 917-22.
11. Suissa S, Ernst P, Boivin J-F et al. A cohort analysis of excess mortality in asthma and the use of inhaled ß-agonists. Am J Respir Crit Care Med 1994; 149: 604-10
12. 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Drug Saf 1994; 11: 259-83.
13. Pearlman DS, Chervmsky P, LaForce C et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma N Engl J Med 1992, 327. 1420-5.
14. D'Alonzo GE, Nathan RA, Henochowicz S, Moms RJ, Ratner P, Rennard SI. Salmeterol xmafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994; 271: 1412-6.
15. Drazen JM, Israel E, Boushey HA et al for the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996, 335: 841-7.
16. Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet L-P, Haukioja A. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol, Am J Respir Crit Care Med 1995; 151: 66-70.
17. Wasserman SI. Furukawa CT, Henochowicz SI et al. Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol. J Allergy Clin Immunol 1995; 95: 541-7.
18. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388-92.
19. Wallin A, Sandström T, Rosenhall L, Melander B. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Thorax 1993; 48: 611-4.
20. 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax. 1988; 43: 674-8.
21. 2 agonist. BMJ 1990; 301: 1365-8
22. Fjellbirkeland L, Gulsvik A, Palmer JBD. The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease. Respir Med 1994; 88: 599-607.
23. Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993; 306: 1034-7.
24. Kesten S, Chapman KR, Broder I et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma Am Rev Respir Dis 1991; 144: 622-5.
25. Maesen FPV. Eformoterol versus salbutamol in patients with ROAD. Br J Clin Pract 1995, (review suppl 81): 8-10.
26. Gibson GJ, Greenacre JK, König P, Conolly ME, Pride NB Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br J Dis Chest 1978, 72: 199-206.
27. Inman MD, O'Byme PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction Am J Respir Crit Care Med 1996; 153. 65-9.
28. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol Respir Med 1994; 88: 363-8.
29. Petrie GR, Chookang JY, Hassan WU et al. Bambuterol: effective in nocturnal asthma. Respir Med 1993; 87: 581-5.
30. Neville E, Corns PA, Vivian J, Nariman S, Gibson GJ. Nebulised salbutamol and angina. BMJ 1982, 285: 796-7.
31. Shaheen MZ, Ayres JG, Benincasa C. Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patients. Eur Respir J 1994; 7: 2160-4.
32. Booth H, Bish R, Walters J, Whitehead F, Walters EH. Salmeterol tachyphylaxis in steroid treated asthmatic subjects. Thorax 1996; 51: 1100-4.